Fosun International’s Alexion Pharmaceuticals ALXN Stock Holding History

Fosun International’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,000	Closed	-$757K	–	241
2019 Q4	$757K	Sell	7,000 -25,900	-79%	-$2.77M	0.06%	132
2019 Q3	$3.22M	Buy	32,900 +28,410	+633%	+$3.2M	0.36%	42
2019 Q2	$566K	Buy	+4,490	New	+$579K	0.04%	213
2019 Q1	–	Sell	-33,224	Closed	-$3.23M	–	336
2018 Q4	$3.23M	Sell	33,224 -21,000	-39%	-$2.48M	0.19%	60
2018 Q3	$7.52M	Buy	54,224 +2,819	+5%	+$354K	0.36%	33
2018 Q2	$6.38M	Buy	51,405 +18,181	+55%	+$2.12M	0.33%	40
2018 Q1	$3.7M	Buy	+33,224	New	+$3.97M	0.23%	40

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Fosun International's ALXN Position: Q1 2020 in Review

Fosun International sold out of Alexion Pharmaceuticals (ALXN) in Q1 2020, closing a stake of 7,000 shares — an estimated $757K sold.

Fosun International first reported a position in ALXN in Q1 2018 and held it in 7 quarters. The position peaked at $7.52M in Q3 2018. 654 funds tracked by Wall St. Rank hold ALXN as of Q1 2020.

Fosun International reported no remaining Alexion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Fosun International sold 7,000 Alexion Pharmaceuticals shares in Q1 2020, an estimated $757K.
Fosun International first reported a position in Alexion Pharmaceuticals in Q1 2018 and held it in 7 quarters.
Fosun International's Alexion Pharmaceuticals position peaked at $7.52M in Q3 2018.
654 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2020.

Based on Fosun International's 13F filing for Q1 2020, filed 11 May 2020.